Objective Telomere shortening is correlated with cell turnover and aging, but it has been recently suggested to occur not only by aging but by several biochemical fac- Results The results demonstrated that HCand/or DM patients with coronary diseases have significantly shorter telomere length than healthy controls (p=0.0014). Conclusion Telomere shortening may be involved in the mechanismsthat promote coronary diseases under some circumstances of metabolic disorders. (Internal Medicine 42: 150-153, 2003) 
Introduction
Telomeres are simple repetitive (TTAGGG)n-sequences located at the ends of chromosomes. They are thought to stabilize chromosomes and prevent them from end-to-end fusions or exonucleolytic degradations (1, 2) . Because of an incapability of DNApolymerases to replicate the very ends of linear DNA,telomeres cannot be replicated completely by this enzyme, which results in a gradual shortening of telomere length with an increasing number of cell divisions and aging (3, 4) . It is well known that there is a linear negative correlation between age and telomere length of peripheral blood mononuclear cells (5) . Recent studies have shown that telomere shortening can be a biomarker of cell senescence and has been discussed on the pathologic relation to various diseases, which include atherosclerosis (6) (7) (8) (9) (10) .
Metabolic disorders such as hypercholesterolemia (HC) or diabetes mellitus (DM)are causally related to atherosclerosis as has been reported by many previous studies. Recently, it has been emphasized that several biochemical factors such as oxygen radicals and elevated plasma homocysteine, which are overproduced in somemetabolic disorders, are responsible for DNAdamage and telomere shortening, and induce atherosclerosis (1 1-14) . Therefore, in the present study, we examined telomere length of peripheral blood mononuclear cells of patients with HCand/or DM,and studied the relation to coronary diseases (CD) to clarify whether or not telomere shortening takes part in the development of atherosclerosis in such metabolic disorders.
For editorial comment, see p 135.
Methods

Sa mples
This study included 91 patients with HC and 84 patients with DM, of whom 35 had both diseases. Thirty healthy volunteers were enrolled as controls, whowereolder than 50 years of age to adjust the meanage of controls to that of patients' group. The criteria for the diagnosis of HC and DM were as follows; serum cholesterol levels^220 mg/dl or under lipid-lowering medication for HC, and fasting blood glucose levels^126 mg/dl on the new criteria or under treatment with per oral antidiabetic medicines for DM.Patients Telomere length analysis High molecular weight genomic DNAwas prepared from each sample by digestion with proteinase K and extraction with phenol/chloroform, and was quantified spectrophotometrically. The molecular size of isolated fragments was estimated to be »40 kb judging from the electrophoresis through 0.7% agarose gels. Equal amounts of DNA(15 \ig) were digested overnight with 10 units/|ug DNAof Hinf I (TaKaRa, Kyoto, Japan) at 37°C to liberate terminal restriction fragments (TRF), which include both subtelomeric repetitive DNA and telomeric TTAGGG repeats. The TRF which determine the telomere lengths were separated by electrophoresis on 0.7% agarose gels, denatured with 0.5 M NaOHand 1.5 MNaCl, and then transferred to nylon membranes (Hybond-N;
Amersham, Buckinghamshire, UK). The membranes were incubated with 5 '-biotinylated oligonucleotide probe (TTAGGG)4 for 3 hours at 48°C in a solution containing 5xstandard saline citrate (SSC), 5xDenhardt's solution and 0.1% sodium dodecyl sulfate (SDS), and were washed with 4xSSC containing 0.1% SDS for 20 minutes at room temperature and subsequently for 30 minutes at 48°C.
The band hybridized with the probe was detected by a chemiluminescence detection kit (Sanko Junyaku, Tokyo, Japan) and visualized by exposure to X-ray film for 30 minutes. Because the TRFsignal was detected as a smear, the mean TRF length was determined by a densitometer (MCID; Imaging Research INC., St. Catherine, Ontario, Canada) which was adjusted for quantification of the smeared telomere hybridization patterns. The position of the mean integrated signal was determined in duplicate for each sample, and used for data analysis. The reproducibility of telomere length analysis was confirmed by repeated examinations of classified the patients into two groups: CD(+) group and CD (-) group. As a result, CD (+) group had a significantly shorter telomere length compared to control, and in the CD (-) group, telomere length was shorter than control, but not significant. (Table 1) Clinical characteristics of the subjects are shown in Table  2 . There were no significant differences in clinical data between CD(+) and CD(-) groups except for the serum glucose level. The serum glucose level of CD(+) group was significantly higher than that of CD(-) group. The presence of DMin the CD(+) group (59 DMpatients of 78 cases; 75.6%) was a higher percentage than that in the CD(-) group (25 DMpatients of 62 cases; 40.3%), and the blood glucose control of DMin CD (+) group (mean fasting blood glucose = 145 mg/dl) was not as good as compared to DM in CD (-) group (mean fasting blood glucose = 129 mg/dl).
These might be the reasons as to why there was a significance observed in the serum blood glucose level. Lipid levels were higher in both patient groups than in controls, but there was no significant difference between CD(+) and CD (-) group. A representative example of Southern blot analysis of telomere length of peripheral blood mononuclear cells is shown in Fig. 1 . In this figure, the CD (+) patient with HC (lane 2) shows a significantly shorter telomere than that of other CD(-) patients and control.
Telomere length of each group is shown in Table 1 . CD (+) group had a significantly shorter telomere length compared to controls. In CD(-) group, the telomere length was shorter than control, but not significant. Wealso studied the effect of the combination of metabolic diseases on the length of telomere as shown in Table 1 .
Each subgroup of CD(+) group had a shorter telomere than the CD(-) group and significantly shorter than control. Each subgroup of CD(-) group had a shorter telomere length than the control group, but not significant.
Discussion
In the present study, we demonstrated that the telomere length of peripheral blood mononuclear cells was significantly shorter in patients with CD. It is reported that telomere shortening occurs in correlation with cell turnover and aging. In addition, the telomere length of peripheral blood mononuclear cells has been reported to decrease gradually with aging, and change in parallel with that of coronary arterial endothelial cells, which may be prone to more rapid shortening than other endothelial cells because of their high turnover rate due to greater blood turbulence (5, 15, 16) . In spite of the importance of telomere length in cell physiology, its regulation remains largely unknown. Al-though the telomere length may reflect the history of tissue replication, it is also suggested that mechanismsother than cellular turnover maytake part in the regulation of telomere length. One of the mechanisms is a pathway mediated by several biochemical factors like oxygen radicals (14) . The structure of chromosomal ends consists of single-stranded overhangs with GGG-triplet repeat sequences, which is a major target of reactive oxygen species (17) . Therefore, the telomere length of human tissues may also be influenced by the extent of oxidative stress, and the shortening of telomere length might be prevented by antioxidant agents (18) . The presence of oxidative stress was found in both HCand DM.
Our previous study indicated that plasma hydroperoxide is increased in HCas a result of oxidative stress even whennot complicated with CD (19) .
It has been reported that inflammatory responses play an important role in the formation of atherosclerotic lesions (20) and mayaccelerate the telomere attrition of vascular endothelial cells, leading to atherosclerosis (10) . These conditions induce premature cell senescence and alteration of cell function such as increased expression of plasminogen activator inhibitor type I (PAI-I), intracellular adhesion molecule I (ICAM-I), and fibronectin, which may contribute to the development of atherosclerosis (13, 21) . The idea is supported by the observations by Campisi that some gene products are expressed differentially in senescent endothelial cells and play pathogenic roles in atherosclerosis (22) . In the injured artery, inflammatory cells participate in the restoration of endothelium and they also have a high cell turnover. Therefore, telomere shortening of peripheral blood mononuclear cells could be an index of increased cell turnover and the biological age of all cell types related to atherosclerosis. Another explanation is the participation of genetic factors commonto both CD and telomere shortening. Telomere length might be determined genetically, because it is highly heritable (5). In fact, telomere length in peripheral blood mononuclear cells is variable and intrinsically determined even among healthy individuals of the same age (23) . If short telomeres are inheritable in CD patients, telomeres might play a primary role in the development of CDby presently unknownmechanisms.
In conclusion, telomere length shortening of peripheral blood mononuclear cells appeared in relation to CDin patients with metabolic diseases such as HCand DM.
